To Study The Effect of Ashwagandha Powder and Amalaki Powder in Post COVID Fatigue Patients

A Clinico-Etiopathological Study To Compare The Efficacy Of Ashwagandha Churna And Amalaki Churna in Post COVID Fatigue Patients-A Randomized Open Label Parallel Group Trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/05/042749

Enrollment

Registered

2022-05-23

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients Recovered From COVID-19.

Exclusion criteria

Exclusion criteria: 1. Pregnant Women And Lactating Mothers. 2. Patients with Severe Dyspnoea. 3. Patients Having Co Morbidities.

Design outcomes

Primary

Measure	Time frame
Improvement In The Fatigue Symptom Of Post COVID PatientsTimepoint: 28 days	—

Secondary

Measure	Time frame
Reduction In The Chalder Fatigue Scale ScoreTimepoint: 28 days	—

Countries

India

Contacts

Public ContactDr Deepak K

Ch.Brahm Prakash Ayurved Charak Sansthan

umeshsapra123@gmail.com8588943505

Outcome results